What is the specific numeric threshold for holding a beta blocker dose and notifying a health care professional?

Correct answer: A heart rate less than 50 bpm

Explanation

This is a quantitative question testing a critical safety parameter for the administration of beta blockers found in the 'Implementation' section.

Other questions

Question 1

What is the primary mechanism of action for beta blockers?

Question 2

Stimulation of which type of beta-adrenergic receptors, primarily found in the heart, results in an increased heart rate and myocardial contractility?

Question 3

According to the text, which of the following is a result of stimulating beta2-adrenergic receptors?

Question 4

Which of the following beta blockers is classified as nonselective, meaning it blocks both beta1- and beta2-adrenergic receptors?

Question 5

Which two beta blockers listed in the text have additional alpha-adrenergic blocking properties?

Question 6

What is the specified use of bisoprolol, carvedilol, and sustained-release metoprolol according to the 'General Use' section?

Question 7

What is a contraindication for the use of beta blockers?

Question 8

In which patient population should beta blockers be used cautiously due to the potential for fetal bradycardia and hypoglycemia?

Question 9

What potential life-threatening event can occur if beta blockers are abruptly withdrawn in patients with cardiovascular disease?

Question 10

Concurrent use of beta blockers with which of the following agents may cause additive myocardial depression and bradycardia?

Question 12

When assessing a patient on beta blocker therapy for signs and symptoms of heart failure (HF), which of the following should be monitored?

Question 13

What advice should be given to a patient taking a beta blocker regarding over-the-counter (OTC) medications?

Question 14

What is a key message to communicate to a patient about the long-term nature of beta blocker therapy for hypertension?

Question 15

What potential effect may exercise or hot weather have on a patient taking a beta blocker?

Question 16

Which of the following drugs is listed as a relatively selective beta1-adrenergic receptor blocker?

Question 17

What is the primary action of ophthalmic beta blockers?

Question 18

Beta blockers are contraindicated in patients with acute bronchospasm and what other heart condition involving rhythm?

Question 19

How might beta blockers interact with bronchodilators?

Question 20

Which drug may decrease the metabolism and increase the effects of some beta blockers?

Question 21

For which of the following conditions is the use of beta blockers for management of symptoms only?

Question 22

What is a listed 'Potential Nursing Diagnosis' for a patient taking beta blockers?

Question 23

What important advice should be given to patients with diabetes who are taking beta blockers?

Question 24

Which of the following is listed as a desired outcome for a patient on beta blocker therapy?

Question 25

What instruction should be given to a patient about their position after taking a beta blocker to minimize a common side effect?

Question 26

Which condition is a contraindication for beta blocker use due to the risk of blocking beta2 receptors in the lungs?

Question 27

In addition to digoxin and diltiazem, which other drug is mentioned as potentially causing additive myocardial depression and bradycardia when used with beta blockers?

Question 28

What is the recommended frequency for a patient on beta blockers to check their BP at home?

Question 29

What type of identification is a patient on beta blocker therapy advised to carry?

Question 30

One of the desired outcomes of beta blocker therapy is the prevention of what serious cardiac event?

Question 31

Which of these beta blockers is NOT listed as being relatively selective for beta1-adrenergic receptors?

Question 32

For what reason should beta blockers be used with caution in any form of lung disease?

Question 33

During nursing assessment for a patient on beta blockers, which parameter should be monitored frequently during dosage adjustment and periodically throughout therapy?

Question 34

What is the primary reason patients on beta blockers are encouraged to comply with interventions like a low-sodium diet and regular exercise?

Question 35

What is a key difference between selective and nonselective beta blockers?

Question 36

Besides decompensated HF and acute bronchospasm, which of the following is also a contraindication for beta blocker use?

Question 37

The nursing assessment for a patient taking a beta blocker for migraine prophylaxis should include assessing the frequency and severity of what?

Question 38

What important piece of advice regarding medication adherence should be given to a patient taking a beta blocker?

Question 39

What is one of the listed desired outcomes related to angina for a patient on beta blockers?

Question 40

How do beta blockers affect patients with diabetes regarding their medication needs?

Question 41

What is the consequence of the interaction between beta blockers and agents like clonidine and ivabradine?

Question 42

In the nursing assessment of a patient on a beta blocker, what specific signs of heart failure related to fluid status should be monitored?

Question 43

What is the primary danger of abruptly discontinuing beta blockers, as mentioned in the patient teaching section?

Question 44

The management of which endocrine disorder is a listed use for beta blockers, although only for symptoms?

Question 45

What does the text say about the use of beta blockers in patients with severe liver disease?

Question 46

If a patient taking a beta blocker experiences arrhythmias, what action should be taken according to the Implementation section?

Question 47

What is one of the therapeutic uses for ophthalmic beta blockers?

Question 48

Why must nonselective beta blockers be used cautiously in patients with lung disease?

Question 49

Which of the following is a key patient teaching point for taking beta blockers for hypertension?

Question 50

A desired outcome of beta blocker therapy, related to vision, is the lowering of what?